Growth-reductive therapy in children with Marfan syndrome

Journal of Pediatrics

Volumn 147, Issue 5, 2005, Pages 674-679

  Rozendaal, L ^c   Le Cessie, S ^e   Wit, J M ^e   Hennekam, R C M ^e   Biesterbos Alders, J M A ^a   Vulsma, T ^a   Hamel, B C J ^b   Otten, B A ^b   Hilhorst Hofstee, Y ^c   Drop, S L S ^d  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e Leiden University Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE; TESTOSTERONE;

ACCURACY; ACNE; ADOLESCENT; AGE; ARTICLE; BODY HEIGHT; BONE AGE; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; GROWTH DISORDER; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; MUSCLE MASS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; BODY HEIGHT; CHILD; DRUG THERAPY, COMBINATION; ETHINYL ESTRADIOL; FEMALE; GROWTH DISORDERS; HUMANS; MALE; MARFAN SYNDROME; MEDROXYPROGESTERONE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT OUTCOME;

EID: 27744489704     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.06.011     Document Type: Article

References (39)

1. H.C. Dietz, G.R. Cutting, R.E. Pyeritz, C.L. Maslen, L.Y. Sakai, and G.M. Corson Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene Nature 352 1991 337 339
2. R.E. Pyeritz The Marfan syndrome Annu Rev Med 51 2000 481 510
3. P. Beighton, A. De Paepe, D. Danks, G. Finidori, T. Geddedahl, and R. Goodman International nosology of heritable disorders of connective-tissue, Berlin, 1986 Am J Med Genet 29 1988 581 594
4. A. De Paepe, R.B. Devereux, H.C. Dietz, R.C.M. Hennekam, and R.E. Pyeritz Revised diagnostic criteria for the Marfan syndrome Am J Med Genet 62 1996 417 426
5. V.A. Mckusick The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue Circulation 11 1955 321 342
6. J.L. Murdoch, B.A. Walker, B.L. Halpern, J.W. Kuzma, and V.A. Mckusick Life expectancy and causes of death in the Marfan syndrome N Engl J Med 286 1972 804 808
7. N. Bayley, and S.R. Pinneau Tables for predicting adult height from skeletal age - revised for use with the Greulich-Pyle hand standards J Pediatr 40 1952 423 441
8. W.W. Greulich, and S.I. Pyle Radiographic atlas of skeletal development of the hand and wrist 1959 Stanford University Press Stanford, California
9. J.M. Tanner, R.H. Whitehouse, W.A. Marshall, and B.S. Carter Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height Arch Dis Child 50 1975 14 26
10. J.M. Tanner, K.W. Landt, N. Cameron, B.S. Carter, and J. Patel Prediction of adult height from height and bone-age in childhood Arch Dis Child 58 1983 767 776
11. J.M. Tanner, R.H. Whitehouse, W.A. Marshall, M.J.R. Healy, and H. Goldstein Assessment of skeletal maturity and prediction of adult height (TW2 method) 1975 Academic Press London
12. A.F. Roche, H. Wainer, and D. Thissen Rwt method for prediction of adult stature Pediatrics 56 1975 1026 1033
13. M. Zachmann, B. Sobradillo, M. Frank, H. Frisch, and A. Prader Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions J Pediatr 93 1978 749 755
14. G. Erkula, K.B. Jones, P.D. Sponseller, H.C. Dietz, and R.E. Pyeritz Growth and maturation in Marfan syndrome Am J Med Genet 109 2002 100 115
15. W.J. de Waal, M.H. GreynFokker, T. Stijnen, E.A.F.J. vanGurp, A.M.P. Toolens, and S.M. de Muinck Keizer-Schrama Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children J Clin Endocrinol Metab 81 1996 1206 1216
16. E.E. Joss, R. Temperli, and P.E. Mullis Adult height in constitutionally tall stature - accuracy of 5 different height prediction methods Arch Dis Child 67 1992 1357 1362
17. E.E. Joss, J. Zeuner, R.P. Zurbrugg, and P.E. Mullis Impact of different doses of ethinyl oestradiol on reduction of final height in constitutionally tall girls Eur J Pediatr 153 1994 797 801
18. A. Prader, and M. Zachmann Treatment of excessively tall girls and boys with sex hormones Pediatrics 62 1978 1202 1210
19. M. Zachmann, A. Ferrandez, G. Murset, H.E. Gnehm, and A. Prader Testosterone treatment of excessively tall boys J Pediatr 88 1976 116 123
20. H.N.B. Wettenhall, C. Cahill, and A.F. Roche Tall girls - survey of 15 years of management and treatment J Pediatr 86 1975 602 610
21. W. Sorgo, K. Scholler, F. Heinze, E. Heinze, and W.M. Teller Critical analysis of height reduction in estrogen-treated tall girls Eur J Pediatr 142 1984 260 265
22. J.H. Bramswig, H.J. Vonlengerke, H. Schmidt, and G. Schellong The results of short-term (6 months) high-dose testosterone treatment on bone-age and adult height in boys of excessively tall stature Eur J Pediatr 148 1988 104 106
23. A. Gruters, P. Heidemann, H. Schluter, P. Stubbe, B. Weber, and H. Helge Effect of different estrogen doses on final height reduction in girls with constitutional tall stature Eur J Pediatr 149 1989 11 13
24. P.C. Hindmarsh, P.J. Pringle, L. Disilvio, and C.G.D. Brook A preliminary-report on the role of somatostatin analog (Sms 201-995) in the management of children with tall stature Clin Endocrinol 32 1990 83 91
25. H.P. Schwarz, E.E. Joss, and K.A. Zuppinger Bromocriptine treatment in adolescent boys with familial tall stature - a pair-matched controlled-study J Clin Endocrinol Metab 65 1987 136 140
26. M.T. Tauber, J.P. Tauber, F. Vigoni, A.G. Harris, and P. Rochicchioli Effect of the long-acting somatostatin analog Sms-201-995 on growth-rate and reduction of predicted adult height in 10 tall adolescents Acta Paediatrica Scandinavica 79 1990 176 181
27. E.K. Normann, O. Trygstad, S. Larsen, and K. Dahljorgensen Height reduction in 539 tall girls treated with 3 different dosages of ethinylestradiol Arch Dis Child 66 1991 1275 1278
28. J. Knudtzon, and D. Aarskog Estrogen treatment of excessively tall girls with Marfan syndrome Acta Paediatr Scand 77 1988 537 541
29. F. Skovby, and V.A. Mckusick Estrogen treatment of tall stature in girls with the Marfan syndrome Birth Defects Orig Artic Ser 13 1977 155 161
30. J.F. Sotos Overgrowth disorders Clin Pediatr (Phila) 35 1996 517 529
31. M.J. Roede, and J.C. van Wieringen Growth diagrams 1980. Netherlands third nationwide survey Tijdschr Soc Gezondheidsz 63 Suppl 1985 1 34
32. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
33. S. De Bie, A. De Paepe, I. Delvaux, S. Davies, and R.C.M. Hennekam Marfan syndrome in Europe J. Borms R. Harspie A. Sand C. Susanne M. Hebbelink Human Growth and Development 1984 Plenum Press New York 423 429
34. J.H. Bramswig, W. Hermeling, W. Petrykowski v, and G. Schellong Comparison of height predictions with final height in boys with constitutional tall stature J. Borms R. Harspie A. Sand C. Susanne M. Hebbelink Human Growth and Development 1984 Plenum Press New York 423 429
35. J.M. Brinkers, P.J. Lamore, E.F. Gevers, B. Boersma, and J.M. Wit The effect of oestrogen treatment on body proportions in constitutionally tall girls Eur J Pediatr 153 1994 237 240
36. J.M. Tanner, R.H. Whitehouse, P.C. Hughes, and B.S. Carter Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children J Pediatr 89 1976 1000 1008
37. A. Venn, F. Bruinsma, G. Werther, P. Pyett, D. Baird, and P. Jones Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility Lancet 364 2004 1513 1518
38. W.J. de Waal, J.T. Vreeburg, F. Bekkering, F.H. de Jong, S.M. de Muinck Keizer-Schrama, and S.L. Drop High dose testosterone therapy for reduction of final height in constitutionally tall boys: does it influence testicular function in adulthood? Clin Endocrinol (Oxf) 43 1995 87 95
39. W.J. de Waal, M. Torn, S.M. de Muinck Keizer-Schrama, R.S. Aarsen, and S.L. Drop Long term sequelae of sex steroid treatment in the management of constitutionally tall stature Arch Dis Child 73 1995 311 315